These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1924511)

  • 1. Cholinergic modulation of oral activity in drug-naive and chronic haloperidol-treated rats.
    See RE; Chapman MA
    Pharmacol Biochem Behav; 1991 May; 39(1):49-54. PubMed ID: 1924511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intermittent and continuous haloperidol regimens produce different types of oral dyskinesias in rats.
    See RE; Ellison G
    Psychopharmacology (Berl); 1990; 100(3):404-12. PubMed ID: 2315437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions between scopolamine and muscarinic cholinergic agonists or cholinesterase inhibitors on spatial alternation performance in rats.
    Shannon HE; Bemis KG; Hendrix JC; Ward JS
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1071-7. PubMed ID: 2262893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scopolamine self-administration: cholinergic involvement in reward mechanisms.
    Glick SD; Guido RA
    Life Sci; 1982 Aug; 31(9):909-13. PubMed ID: 7176819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of chronic administration of haloperidol and the atypical neuroleptics, clozapine and raclopride, in an animal model of tardive dyskinesia.
    See RE; Ellison G
    Eur J Pharmacol; 1990 Jun; 181(3):175-86. PubMed ID: 2384130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modification of apomorphine-, physostigmine- and pilocarpine-induced yawning after long-term treatment with neuroleptic or cholinergic agents.
    Ushijima I; Noda Y; Mizuki Y; Yamada M
    Arch Int Pharmacodyn Ther; 1984 Oct; 271(2):180-8. PubMed ID: 6150689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholinergic manipulation of perioral behaviour induced by chronic neuroleptic administration to rats.
    Rupniak NM; Jenner P; Marsden CD
    Psychopharmacology (Berl); 1983; 79(2-3):226-30. PubMed ID: 6133305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of oral movements in rats during and after chronic haloperidol and fluphenazine administration.
    See RE; Levin ED; Ellison GD
    Psychopharmacology (Berl); 1988; 94(3):421-7. PubMed ID: 3128820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopaminergic and cholinergic interaction in cataleptic responses in mice.
    Ushijima I; Kawano M; Kaneyuki H; Suetsugi M; Usami K; Hirano H; Mizuki Y; Yamada M
    Pharmacol Biochem Behav; 1997 Sep; 58(1):103-8. PubMed ID: 9264077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of cholinergic drugs on prey-killing by rodents.
    Wnek DJ; Leaf RC
    Physiol Behav; 1973 Jun; 10(6):1107-13. PubMed ID: 4736903
    [No Abstract]   [Full Text] [Related]  

  • 11. Cholinergic stimulation of the ventrolateral striatum elicits mouth movements in rats: pharmacological and regional specificity.
    Kelley AE; Bakshi VP; Delfs JM; Lang CG
    Psychopharmacology (Berl); 1989; 99(4):542-9. PubMed ID: 2594921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopaminergic and cholinergic influences on morphine self-administration in rats.
    Glick SD; Cox RD
    Res Commun Chem Pathol Pharmacol; 1975 Sep; 12(1):17-24. PubMed ID: 1188183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discriminative stimulus properties of muscarinic agonists.
    Jung M; Costa L; Shearman GT; Kelly PH
    Psychopharmacology (Berl); 1987; 93(2):139-45. PubMed ID: 3122245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioural and pharmacological characterization of the mouth movements induced by muscarinic agonists in the rat.
    Salamone JD; Lalies MD; Channell SL; Iversen SD
    Psychopharmacology (Berl); 1986; 88(4):467-71. PubMed ID: 3085134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of yawning behavior induced by apomorphine, physostigmine and pilocarpine.
    Ushijima I; Mizuki Y; Imaizumi J; Yamada M; Noda Y; Yamada K; Furukawa T
    Arch Int Pharmacodyn Ther; 1985 Feb; 273(2):196-201. PubMed ID: 4004417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muscarinic and nicotinic effects on yawning and tongue protruding in the rat.
    Ushijima I; Yamada K; Inoue T; Tokunaga T; Furukawa T; Noda Y
    Pharmacol Biochem Behav; 1984 Aug; 21(2):297-300. PubMed ID: 6541344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of apomorphine-induced climbing in mice by cholinergic drugs and neuroleptics.
    Lassen JB
    Acta Pharmacol Toxicol (Copenh); 1979 Aug; 45(2):161-5. PubMed ID: 40391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of cholinergic agonists on the dorsal immobility response.
    Potter TJ; Cottrell GA; Van Hartesveldt C
    Pharmacol Biochem Behav; 1990 May; 36(1):77-80. PubMed ID: 2349272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholinergic mechanisms involved in head-shaking of infant rats.
    Holmgren B; Urba-Holmgren R
    Pharmacol Biochem Behav; 1977 Dec; 7(6):493-9. PubMed ID: 594096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholinergic manipulations in the rat basolateral amygdaloid nucleus on locomotor activity induced by amphetamine.
    Gómez MN; Campos HA
    Brain Res; 1987 Feb; 404(1-2):304-6. PubMed ID: 3567573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.